Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL-Reference-Cited by-同舟云学术

Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL

Published:2013-10 Issue:43 Volume:288 Page:31268-31279
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Kaiser William J.,Sridharan Haripriya,Huang Chunzi,Mandal Pratyusha,Upton Jason W.,Gough Peter J.,Sehon Clark A.,Marquis Robert W.,Bertin John,Mocarski Edward S.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference60 articles.

1. Manipulation of host cell death pathways during microbial infections;Lamkanfi;Cell Host Microbe,2010

2. Apoptosis: an innate immune response to virus infection;Everett;Trends Microbiol,1999

3. Pathogen recognition by the innate immune system;Kumar;Int. Rev. Immunol,2011

4. Apoptosis induced by the toll-like receptor adapter TRIF is dependent on its receptor interacting protein homotypic interaction motif;Kaiser;J. Immunol,2005

5. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway;He;Proc. Natl. Acad. Sci. U.S.A,2011

Cited by 759 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications;Non-coding RNA Research;2024-12

2. Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis;Current Opinion in Structural Biology;2024-10

3. Shikonin and chitosan-silver nanoparticles synergize against triple-negative breast cancer through RIPK3-triggered necroptotic immunogenic cell death;Biomaterials;2024-09

4. Low levels of supercoiled mitochondrial DNA are involved in heart failure induced by transverse aortic constriction in mice via an inflammatory response mediated by ZBP1;Experimental Cell Research;2024-09

5. Necroptosis and autoimmunity;Clinical Immunology;2024-09